Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of BC-T4CYS vs Letrox in Healthy Subjects
NCT06547242Phase 1Completed
- Sponsor
- Menarini Group
- Start
- Oct 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of levothyroxine sodium in hypothyroidism (2 arms), sponsored by Menarini Group. Primary endpoints: Area Under the Curve from time 0 to 72 hours and Maximum Plasma Concentration. Started Oct 2021; status: completed.
02
Drugs
levothyroxine sodium
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on NCT06547242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06547242.